|
|
|
Volumn 26, Issue 1 SUPPL. 2, 1999, Pages 44-54
|
|
Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIFOSTINE;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
GEMCITABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IRINOTECAN;
MONOCLONAL ANTIBODY;
NAVELBINE;
PACLITAXEL;
PLATINUM DERIVATIVE;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
BONE MARROW TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG INDUCED DISEASE;
ESOPHAGITIS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
|
|
EID: 0033041767
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (26)
|
|
References (43)
|
